2023 annual financial data
PTC Therapeutics 2023 Operating margin
PTC Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -46.86%.
Operating income was -439,502,000 USD and net income was -626,604,000 USD.
Operating cash flow was -158,418,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 937,822,000 USD
- Operating income
- -439,502,000 USD
- Net income
- -626,604,000 USD
- Operating cash flow
- -158,418,000 USD